Navigation Links
WellPoint Foundation Awards Grants to OASIS to Expand Unique Active Generations Program
Date:2/25/2009

OASIS is a national education organization dedicated to enriching the lives of adults age 50 and older through lifelong learning and service. Offering stimulating programs in the arts, humanities, health, technology and volunteer service, OASIS brings people together to learn, lead and contribute in their communities. The OASIS Institute in St. Louis is the headquarters of a national network that serves a diverse audience through educational centers and community partners in 27 U.S. cities. For more information, visit www.oasisnet.org


'/>"/>
SOURCE OASIS
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting
2. WellPoint Announces Appearance at 2nd Annual Medicaid Managed Care Summit
3. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
4. WellPoint Joins New York Attorney General in Creation of New Independent Database for Out-of-Network Reimbursement
5. WellPoint Announces Webcast of its Conference with Investment Community
6. WellPoint Applauds President Obama for Signing SCHIP Reauthorization
7. WellPoint Reports Fourth Quarter and Full Year 2008 Results
8. WellPoint to Reduce Operating Expenses for Continued Long-Term Success
9. WellPoint Statement on CMS Action
10. WellPoint Receives Seven eHealthcare Leadership Awards
11. WellPoint Announces Appearance at Upcoming Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ov.23/PRNewswire/--VictoryPharma,Inc.("Victory")an...therextensionofVictory,sNAPRELANfranchise. ,, N...effrommildtomoderatepainandinflammationassociatedw...s.Itisalsodesignedforpatientssufferingfromrheumato...herapiesandneedadditionalanti-inflammatory/analges...
(Date:11/23/2009)...n changes offer clues to treatment advances, study...ws) -- The protein content of saliva changes as pe...s may help lead to a simple test to diagnose and t..., Human saliva contains numerous proteins that pl...r functions. Researchers are trying to find ways t...
(Date:11/23/2009)...fat on their waist in middle age are more than twi...er, reveals a new study from the Sahlgrenska Acade...cientific journal Neurology . , "Anyone carryin...k of dying prematurely due to a heart attack or st...the Sahlgrenska Academy. "If they nevertheless man...
(Date:11/23/2009)...he Medical College of Georgia is leading an initia...care of patients with sickle cell disease. , Mo...ty of Florida are partners in the initiative that ...a to serve as "medical homes" for patients, changi...ds them to the hospital and seeking better prevent...
(Date:11/23/2009)... Life-Science Focused Strategic Communicati... Communication Professionals , ...e Group, a life science-focused strategic communic...d the 2009 MarCom Gold Award in the design/website...Association of Marketing and Communication Profess...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3
...can Heart Association (AHA) laid a new set of diet...which were offered by various organizations //such...e Pyramid and food recommendations from the Nation...by all are increased intake of fruit and vegetable...
...ya, a relatively rare form of mosquito-transmitted...adesh and hundreds are suffering from the disease,...s been reported in Madhya Pradesh for the first ti...e to the victim as a result of the arthritic sympt...
... symptom of Sj?gren’s (SHOW-grins) syndrome was fo... which lasts for long periods. Typical signs a...ntermittent blurry vision, a dry mouth that causes...ars. Other signs and symptoms may include dry skin...
...at is responsible for approving NHS treatments ha..., after it blocked the usage of an anti-cancer d...to asbestos will not be treated with the drug Alim...The group analyzed the cost effectiveness of the d...
...on is made easy but the new fat-busting laser trea...ritain and is claimed to be a quicker and less inv...lumps of fat in the thighs, bottom and in the doub...g Administration (FDA) has not approved to the pro...
... to a study by the investigators at John Hopkins C... improved by reporting as well as recording the me...kins researchers said ‘Human error rates are minim...ems are not new, but few studies have looked at th...
Other Medicine News:Health News:Voluntary Error-Reporting System Ensures Patient Safety 2Health News:Voluntary Error-Reporting System Ensures Patient Safety 3Health News:Voluntary Error-Reporting System Ensures Patient Safety 4
(Date:11/23/2009)...e-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS )announ...Roche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinuefor...ase2btrialofRG7128,afirst-in-classnucleosideanalog...isCvirus(HCV)infection.Thedecisionwasreachedaftera...tee(DMC)ofallavailablesafetydatafromthefirstcohort...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...romaPhase2bclinicaltrialofitsproprietarydelayed-re...swithnephropathiccystinosis("cystinosis").Thetrial...SD")GeneralClinicalResearchCenter,evaluatedsafety,...asingledoseofDRCysteamineinninecystinosispatients....
(Date:11/23/2009)...wire-FirstCall/--Oceanside Pharmaceuticals ,partof...todayannouncedthatithasnowlaunchedchlordiazepoxide...ic(AG)versionofLibrax®.Oceansidehasreceivedit...ibrax®genericmarket. ,, "Valeant,sOceansid...withitssuccessfullaunchanddistributionof5%fluorour...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2RF Technologies Achieves Premier Certification From Cisco in United States 52288 1RF Technologies Achieves Premier Certification From Cisco in United States 52288 2Young Black Hispanic Women Tend to Develop Love Handles 52284 1Young Black Hispanic Women Tend to Develop Love Handles 52284 2THA Honors 12 Legislators for Contributions to Health Care 52280 1THA Honors 12 Legislators for Contributions to Health Care 52280 2
... Ill., Sept. 22 Baxter Healthcare,Corporation tod...ial,following U.S. Food and Drug Administration (F...tion to evaluate GAMMAGARD LIQUID [Immune,Globulin...an Union, for the,treatment of mild-to-moderate Al...e first of two pivotal Phase III trials required t...
...tario, Sept. 22 Helix BioPharma announced,today t...vals to open,clinical sites in Germany to expand u...ha-2b in patients with ano-genital warts, which is...o have received approval to open these additional,...Helix BioPharma. "The,opening of sites in Germany ...
Other Medicine Technology:Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 2Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 3Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 4Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 5Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: